申请人:——
公开号:US20030130518A1
公开(公告)日:2003-07-10
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and urea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
含有醚和尿素功能团在1-位置的咪唑喹啉和四氢咪唑喹啉化合物在免疫应答调节剂方面具有用处。该发明的化合物和组合物可以诱导各种细胞因子的生物合成,并可用于治疗包括病毒性疾病和肿瘤性疾病在内的各种疾病。